These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 14627129)

  • 1. Preclinical evaluation of anti-CD86 immunotoxin in rhesus monkeys: analysis of systemic toxicity, pharmacokinetics, and effect on primary T-cell responses.
    Otten HG; de Gast GC; Vooijs WC; van der Gouw AP; de Boer M; Ossevoort MA; Jonker M
    Cancer Immunol Immunother; 2003 Sep; 52(9):569-75. PubMed ID: 14627129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of immunotoxins directed against CD80 and CD86 on primary T-cell alloresponses.
    Otten HG; Vooijs WC; van der Gouw L; de Boer M; de Gast GC
    Tissue Antigens; 1998 Sep; 52(3):270-4. PubMed ID: 9802607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of primary T-cell responses by immunotoxins directed against CD80 and CD86.
    Otten HG; Vooijs WC; van der Gouw AP; de Boer M; de Gast GC
    Transplant Proc; 1997; 29(1-2):1034-5. PubMed ID: 9123185
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro anti-tumour activity of anti-CD80 and anti-CD86 immunotoxins containing type 1 ribosome-inactivating proteins.
    Bolognesi A; Polito L; Tazzari PL; Lemoli RM; Lubelli C; Fogli M; Boon L; de Boer M; Stirpe F
    Br J Haematol; 2000 Aug; 110(2):351-61. PubMed ID: 10971392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward preclinical studies with anti-CD86 immunotoxin.
    Otten HG; Ossevoort M; Vooijs WC; van der Gouw AP; de Boer M; de Gast GC
    Transplant Proc; 1999; 31(1-2):1236. PubMed ID: 10083551
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention of renal allograft rejection in primates by blocking the B7/CD28 pathway.
    Ossevoort MA; Ringers J; Kuhn EM; Boon L; Lorré K; van den Hout Y; Bruijn JA; de Boer M; Jonker M; de Waele P
    Transplantation; 1999 Oct; 68(7):1010-8. PubMed ID: 10532543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the systemic toxicity and pharmacokinetics of the immunoconjugate anti-B4-blocked ricin in non-human primates. Delivered by multiple bolus injections and by continuous infusion.
    Shah SA; Lambert JM; Goldmacher VS; Esber HJ; Levin JL; Chungi V; Zutshi A; Braman GM; Ariniello PD; Taylor JA
    Int J Immunopharmacol; 1993 Aug; 15(6):723-36. PubMed ID: 7691767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction therapy with monoclonal antibodies specific for CD80 and CD86 delays the onset of acute renal allograft rejection in non-human primates.
    Kirk AD; Tadaki DK; Celniker A; Batty DS; Berning JD; Colonna JO; Cruzata F; Elster EA; Gray GS; Kampen RL; Patterson NB; Szklut P; Swanson J; Xu H; Harlan DM
    Transplantation; 2001 Aug; 72(3):377-84. PubMed ID: 11502964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional expression of CD80 and CD86 allows immunogenicity of malignant B cells from non-Hodgkin's lymphomas.
    Chaperot L; Plumas J; Jacob MC; Bost F; Molens JP; Sotto JJ; Bensa JC
    Exp Hematol; 1999 Mar; 27(3):479-88. PubMed ID: 10089910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Costimulatory molecules (CD80 and CD86) on Reed-Sternberg cells are associated with the proliferation of background T cells in Hodgkin's disease.
    Nozawa Y; Wakasa H; Abe M
    Pathol Int; 1998 Jan; 48(1):10-4. PubMed ID: 9589458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of B7-2 (CD86) molecules by Reed-Sternberg cells of Hodgkin's disease.
    Van Gool SW; Delabie J; Vandenberghe P; Coorevits L; De Wolf-Peeters C; Ceuppens JL
    Leukemia; 1997 Jun; 11(6):846-51. PubMed ID: 9177439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The B7/BB1 antigen is expressed by Reed-Sternberg cells of Hodgkin's disease and contributes to the stimulating capacity of Hodgkin's disease-derived cell lines.
    Delabie J; Ceuppens JL; Vandenberghe P; de Boer M; Coorevits L; De Wolf-Peeters C
    Blood; 1993 Nov; 82(9):2845-52. PubMed ID: 7693051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-cell alterations in cardiac allograft recipients after B7 (CD80 and CD86) blockade.
    Woodward JE; Bayer AL; Chavin KD; Blue ML; Baliga P
    Transplantation; 1998 Jul; 66(1):14-20. PubMed ID: 9679816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased inducible expression of CD80 and CD86 in human monocytes after ultraviolet-B irradiation: its involvement in inactivation of allogenecity.
    Fujihara M; Takahashi TA; Azuma M; Ogiso C; Maekawa TL; Yagita H; Okumura K; Sekiguchi S
    Blood; 1996 Mar; 87(6):2386-93. PubMed ID: 8630402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of B7-1 (CD80) and B7-2 (CD86) costimulatory molecules and dendritic cells on the immune response in leprosy.
    Santos DO; Santos SL; Esquenazi D; Nery JA; Defruyt M; Lorré K; Van Heuverswyn H
    Nihon Hansenbyo Gakkai Zasshi; 2001 Feb; 70(1):15-24. PubMed ID: 11244783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivery of the ribosome-inactivating protein, gelonin, to lymphoma cells via CD22 and CD38 using bispecific antibodies.
    French RR; Penney CA; Browning AC; Stirpe F; George AJ; Glennie MJ
    Br J Cancer; 1995 May; 71(5):986-94. PubMed ID: 7734325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of murine Lyme borreliosis by interruption of the B7/CD28 T-cell costimulatory pathway.
    Shanafelt MC; Kang I; Barthold SW; Bockenstedt LK
    Infect Immun; 1998 Jan; 66(1):266-71. PubMed ID: 9423867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates. IV. Cytotoxic effect of an anti-T11-gelonin immunotoxin.
    Reimann KA; Goldmacher VS; Lambert JM; Chalifoux LV; Cook SB; Schlossman SF; Letvin NL
    J Clin Invest; 1988 Jul; 82(1):129-38. PubMed ID: 2899092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular cloning and comparative analysis of the rhesus macaque costimulatory molecules CD80 (B7-1) and CD86 (B7-2).
    Zhang D; Johnson RP
    Cell Immunol; 1997 Apr; 177(1):9-17. PubMed ID: 9140091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response of refractory Hodgkin's disease to monoclonal anti-CD30 immunotoxin.
    Falini B; Bolognesi A; Flenghi L; Tazzari PL; Broe MK; Stein H; Dürkop H; Aversa F; Corneli P; Pizzolo G
    Lancet; 1992 May; 339(8803):1195-6. PubMed ID: 1349939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.